Friday, March 24, 2006


Hep C Virus - Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year results: Good progress


Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year results: Good progress
n-tv.de - Mar 05 10:31 PM
Disclosure announcement transmitted by euro adhoc.Save to My Web

AVI BioPharma Successful Ebola Study Results Highlighted in Nature Reviews Drug Discovery
[Press Release] Business Wire via Yahoo! Finance - Mar 07 6:00 AM
PORTLAND, Ore.----March 7, 2006--AVI BioPharma, Inc. , today announced that the February issue of Nature Reviews Drug Discovery chose to highlight the company's recent Ebola study results.Save to My Web

Coley Pharmaceutical Group Initiates Phase II Clinical Study of Actilon(TM) for Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 5:30 AM
Coley Pharmaceutical Group, Inc. today announced the initiation of a randomized Phase II clinical study of Actilon for the treatment of patients with chronic Hepatitis C infection.Save to My Web

Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in
[Press Release] PR Newswire via Yahoo! Finance - Feb 27 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in-class anti-viral compound Tarvacin Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus infected patients.Save to My Web

Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds
[Press Release] PR Newswire via Yahoo! Finance - Mar 20 5:30 AM
Schering-Plough Corporation and PTC Therapeutics, Inc. today announced that they have entered into an exclusive collaboration and licensing agreement for the development of PTC's preclinical compounds for the oral treatment of hepatitis C virus infection and other viral diseases.Save to My Web